Company intelligence / Profile preview

Qualissima

Ownership: Private
Development stage: Other

Overview

Qualissima provides comprehensive clinical research services from development planning through execution and management of clinical trials in phases I–IV. They support proof-of-concept studies and observational studies for both drugs and medical devices. No proprietary drug or device results are reported as they operate as a service provider.

Modalities: Small moleculeMedical device
Industry: Contract Research Organization

Partnerships

Collaborates with pharmaceutical companiesCollaborates with public research organizations

Beyond the preview

Go deeper on Qualissima.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qualissima.

Explore the full profile